Dyne Therapeutics CEO and President John Cox sold 5,658 shares at $18.88 per share on Sep. 8, 2026. Cox retained 357,507 shares after the transaction, giving investors the reported ownership figure for the company’s chief executive following the sale.

Key Highlights

  • Dyne Therapeutics CEO and President John Cox held 357,507 shares after the transaction.
  • The sale was recorded under transaction code S.
  • Cox completed the transaction on Sep. 8, 2026.

Dyne Therapeutics, Inc. (NASDAQ: DYN) CEO and President John Cox sold 5,658 shares at $18.88 per share on Sep. 8, 2026. The transaction left Cox with 357,507 shares.

John Cox’s 5,658-Share Transaction

The sale was recorded under transaction code S. Cox’s position following the transaction was 357,507 shares of Dyne Therapeutics, Inc. The reported sale involved 5,658 shares, with each share priced at $18.88. Cox’s role at Dyne Therapeutics is CEO and President. The transaction date was Sep. 8, 2026. The reported post-transaction holding was measured after the sale had taken place. The per-share price was $18.88. The number of shares sold was 5,658. Cox’s resulting ownership was 357,507 shares.